We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
(+13%)
Cap. Flow
+$2.18B
Cap. Flow
% of AUM
18.39%
Top 10 Holdings %
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$34.6M |
| 2 |
Workday
WDAY
|
+$33.5M |
| 3 |
FRC
First Republic Bank
FRC
|
+$31.8M |
| 4 |
Zoetis
ZTS
|
+$31.3M |
| 5 |
Synchrony
SYF
|
+$31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$35.7M |
| 2 |
Honeywell
HON
|
+$31.7M |
| 3 |
International Paper
IP
|
+$30.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$23.8M |
| 5 |
Emerson Electric
EMR
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.12% |
| 2 | Financials | 17.75% |
| 3 | Healthcare | 12.17% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Industrials | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Conduent
CNDT
$249M
| $466K | ﹤0.01% |
90,307
-69,136
| -43% | -$340K |
|
2577
HealthEquity
HQY
$8.77B
| $466K | ﹤0.01% |
6,910
-143,152
| -95% | -$7.73M |
|
2578
Sensus Healthcare
SRTS
$52.8M
| $466K | ﹤0.01% |
46,006
+7,084
| +18% | +$64.7K |
|
|
MYOV
2579
DELISTED
Myovant Sciences Ltd.
MYOV
| $466K | ﹤0.01% |
34,960
+13,835
| +65% | +$186K |
|
|
CLDT
2580
Chatham Lodging
CLDT
$600M
| $464K | ﹤0.01% |
+33,667
| New | +$462K |
|
2581
Liberty Latin America Class A
LILA
$1.67B
| $464K | ﹤0.01% |
70,409
+21,571
| +44% | +$155K |
|
2582
Sterling Infrastructure
STRL
$16.9B
| $464K | ﹤0.01% |
17,304
-28,243
| -62% | -$789K |
|
|
HA
2583
DELISTED
Hawaiian Holdings, Inc.
HA
| $463K | ﹤0.01% |
+23,527
| New | +$437K |
|
2584
Broadridge
BR
$19.4B
| $462K | ﹤0.01% |
2,970
-2,761
| -48% | -$424K |
|
2585
Nelnet
NNI
$4.53B
| $462K | ﹤0.01% |
+5,433
| New | +$468K |
|
|
HDSN
2586
Hudson Technologies
HDSN
$239M
| $461K | ﹤0.01% |
74,242
+56,746
| +324% | +$252K |
|
|
BCSAU
2587
DELISTED
Blockchain Coinvestors Acquisition Corp. I Unit
BCSAU
| $461K | ﹤0.01% |
+45,456
| New | +$460K |
|
|
ARR
2588
Armour Residential REIT
ARR
$2.37B
| $460K | ﹤0.01% |
10,956
+8,626
| +370% | +$385K |
|
2589
Organon & Co
OGN
$3.6B
| $459K | ﹤0.01% |
+13,127
| New | +$449K |
|
|
RVNC
2590
DELISTED
Revance Therapeutics, Inc.
RVNC
| $458K | ﹤0.01% |
23,505
-32,001
| -58% | -$485K |
|
2591
Bank of N.T. Butterfield & Son
NTB
$2.51B
| $457K | ﹤0.01% |
12,729
-1,371
| -10% | -$52K |
|
|
ETWO
2592
DELISTED
E2open Parent Holdings
ETWO
| $455K | ﹤0.01% |
51,648
+31,700
| +159% | +$288K |
|
|
UDMY
2593
DELISTED
Udemy
UDMY
| $455K | ﹤0.01% |
36,478
-9,028
| -20% | -$125K |
|
2594
Curis
CRIS
$3.34M
| $454K | ﹤0.01% |
477
+118
| +33% | +$151K |
|
2595
Gentex
GNTX
$5.01B
| $454K | ﹤0.01% |
15,557
-48,826
| -76% | -$1.52M |
|
|
DQ
2596
Daqo New Energy
DQ
$1B
| $453K | ﹤0.01% |
+10,957
| New | +$461K |
|
|
LUXE
2597
LuxExperience B.V.
LUXE
$1.04B
| $453K | ﹤0.01% |
+37,058
| New | +$562K |
|
2598
SBA Communications
SBAC
$19.8B
| $453K | ﹤0.01% |
1,316
-20,480
| -94% | -$6.64M |
|
|
GTAC
2599
DELISTED
Global Technology Acquisition Corp. I Class A Ordinary Shares
GTAC
| $453K | ﹤0.01% |
+45,558
| New | +$451K |
|
2600
Acadia Healthcare
ACHC
$2.83B
| $451K | ﹤0.01% |
6,880
-12,797
| -65% | -$743K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q1 2022 Portfolio in Review
As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.
- Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
- Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
- Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
- Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
- Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
- Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
- Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.
Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.